Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) EBIT (2016 - 2022)

Inogen (INGN) has disclosed EBIT for 10 consecutive years, with -$10.3 million as the latest value for Q3 2022.

  • On a quarterly basis, EBIT fell 261.47% to -$10.3 million in Q3 2022 year-over-year; TTM through Sep 2022 was $1.1 million, a 89.76% decrease, with the full-year FY2021 number at $9.2 million, up 176.84% from a year prior.
  • EBIT was -$10.3 million for Q3 2022 at Inogen, down from -$6.7 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $14.0 million in Q2 2018 to a low of -$10.3 million in Q3 2022.
  • A 5-year average of $2.9 million and a median of $4.8 million in 2018 define the central range for EBIT.
  • Peak YoY movement for EBIT: surged 596.43% in 2021, then tumbled 261.47% in 2022.
  • Inogen's EBIT stood at $4.8 million in 2018, then tumbled by 211.43% to -$5.3 million in 2019, then fell by 3.78% to -$5.5 million in 2020, then dropped by 20.84% to -$6.7 million in 2021, then tumbled by 54.23% to -$10.3 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's EBIT are -$10.3 million (Q3 2022), -$6.7 million (Q4 2021), and $6.4 million (Q3 2021).